Evaluation of the Symptoms and Clinical Characteristics of Crohn’s Disease and Ulcerative Colitis That Affect Healthcare Providers’ Treatment Choices
Our study provides real-world insights into the symptoms and clinical characteristics that most impact HCPs' treatment choices for CD and UC in clinical practice.
Authors
- Theresa Hunter (ORCID: https://orcid.org/0000-0001-8412-9175)
- David McSorley (ORCID: https://orcid.org/0000-0002-6122-2083)
- Richard Moses (ORCID: https://orcid.org/0000-0002-1423-089X)
- Marla Dubinsky
- Daniel Wolin (ORCID: https://orcid.org/0009-0004-4437-8424)
- Carolyn Sweeney (ORCID: https://orcid.org/0000-0002-1538-5893)
- Jinyi Wang (ORCID: https://orcid.org/0000-0001-6013-1422)
Institutions
- Eli Lilly (United States) (US)
- RTI Health Solutions (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Crohn s & Colitis 360
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1093/crocol/otae053
- Citations
- 3
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.65
Funders
- Eli Lilly and Company